Clinical Trial Update: A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE) [Phase 4]

View source ↗

Summary

Phase 4 trial assessing rhPTH(1-84) for symptom improvement and metabolic control in adults with hypoparathyroidism has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism

Drugs mentioned

• rhPTH(1-84) (recombinant human parathyroid hormone 1-84)

Snippet

Sponsor: Shire | Conditions: Hypoparathyroidism | Phase 4 | Status: COMPLETED | Results posted: 2023-06-09